Itau Unibanco Holding S.A.’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding MRTX
Itau Unibanco Holding S.A.'s MRTX Position: Q1 2024 in Review
Itau Unibanco Holding S.A. sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 135 shares — an estimated $7.93K sold.
Itau Unibanco Holding S.A. first reported a position in MRTX in Q2 2021 and held it in 11 quarters. The position peaked at $32K in Q4 2021. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.
- Itau Unibanco Holding S.A. reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Itau Unibanco Holding S.A. sold 135 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $7.93K.
- Itau Unibanco Holding S.A. first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2021 and held it in 11 quarters.
- Itau Unibanco Holding S.A.'s Mirati Therapeutics, Inc. Common Stock position peaked at $32K in Q4 2021.
- 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Itau Unibanco Holding S.A.'s 13F filing for Q1 2024, filed 14 May 2024.